Full text is available at the source.
Abstract
Neutrophilic asthma (NA) is characterized by a network of mediators including IL-6, IL-8, IL-17, IL-1β, TNF-α, and IFN-γ that drive severe inflammation.
- NA is associated with T2-low airway inflammation, which complicates treatment options.
- Aging-related cells contribute to NA by releasing factors that promote chronic inflammation.
- The senescence-associated secretory phenotype (SASP) may play a critical role in neutrophilic inflammation.
- Disruption of the cycle involving aging, inflammation, and steroid resistance could offer new therapeutic strategies.
- An incomplete understanding of NA's pathogenesis hinders the identification of targeted therapies.
Simplified